ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
150,806 announcements
Greenply delivered a record-breaking Q4 with its highest-ever quarterly revenue, driven by strong growth in MDF and Plywood segments despite significant management transition and geopolitical supply chain headwinds.
Sona Comstar reported strong FY26 performance with 26% revenue growth and 13% EBITDA growth, though margins contracted by 270bps due to adverse product mix and fixed costs.
Tenneco Clean Air India Limited clarified to the NSE that recent share price and volume movements are entirely attributable to market conditions. The company confirmed it has promptly disclosed all material events and is unaware of any undisclosed underlying reasons for the trading activity.
Sona Comstar reported strong FY26 performance with 26% revenue growth and 13% EBITDA growth, driven by expansion into non-automotive and electric mobility segments.
Aster DM Healthcare reported Q4 FY26 proforma revenue of ₹2,361 Crore, up 18% YoY, with operating EBITDA increasing 25% to ₹517 Crore. The merger with Quality Care India Limited (QCIL) received 96.68% shareholder approval. The combined entity's capacity will exceed 10,623 beds, positioning it among India's top three healthcare providers.
Dr. Lal PathLabs reported strong Q4 FY26 revenue growth of 16.6% YoY, driven by volume momentum. The company is focusing on digital transformation and expanding into Tier 3+ markets.
Shreyas Intermediates Ltd confirmed it is not classified as a 'Large Corporate' as of March 31, 2026, under SEBI debt issuance norms. The company reported zero outstanding borrowings for the period. This disclosure is part of annual regulatory compliance regarding borrowing frameworks for large entities.
Kalana Ispat Limited informed the exchange that the submission of the Annual Secretarial Compliance Report for FY 2025-26 is not applicable. The company qualifies for exemption under SEBI LODR Regulation 15(2) due to its listing on the NSE SME Platform. The company committed to future compliance should it cross the regulatory thresholds.
Dr. Lal PathLabs delivered steady growth in Q4 FY26, with revenue rising 16.6% YoY to ₹703 cr. Performance was driven by high sample volumes and expansion into Tier 3+ markets.
GHCL Textiles Limited's board recommended appointing Deloitte Haskins & Sells as Statutory Auditors for a five-year term starting from the 6th AGM. Additionally, the board approved re-appointing SPMB & Co. LLP as Internal Auditors and R J GOEL & CO. as Cost Auditors for FY 2026-27.
5paisa Capital Limited granted 50,000 stock options to identified employees at an exercise price of ₹10 per share. The options vest after a minimum of one year and have a three-year exercise period from the vesting date. This grant is part of the company's 2023 Employee Stock Option Scheme.
Orient Electric Limited has scheduled a board meeting for May 8, 2026. The board will consider audited standalone financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 10, 2026.
R R Kabel Limited's Board approved the re-appointment of internal, cost, and tax auditors for a 12-month term starting April 1, 2026. PricewaterhouseCoopers remains internal auditor, while B S R & Co. LLP continues as tax auditor.
Credent Global Finance Limited confirmed it does not qualify as a 'Large Corporate' as of March 31, 2026. The company reported outstanding long-term borrowings below ₹1,000 Crores and lacks high-grade credit ratings on unsupported bank borrowings, exempting it from specific SEBI debt issuance disclosure requirements.
Kesar Enterprises Limited confirmed it does not qualify as a 'Large Corporate' under SEBI norms for the financial year ending March 31, 2026. The company reported outstanding borrowings of ₹59.25 Crore and carries a credit rating of 'CARE D' from CARE Edge Ratings.
Power Finance Corporation Limited has appointed Shri Rajesh Kumar Agarwal as Chief Financial Officer for a five-year term effective April 23, 2026. Agarwal, previously Executive Director (Finance), brings 31 years of experience in power and finance sectors. The appointment follows a board meeting held on April 30, 2026.
Dr. Lal PathLabs Limited reported Q4 FY26 revenue of ₹703 Crore, marking 16.6% year-on-year growth. EBITDA for the quarter rose 10.5% to ₹187 Crore with a 26.6% margin, while PAT stood at ₹132 Crore. The company also declared a final dividend of 40% (Rs. 4 per share).
Corona Remedies Ltd has scheduled a Board Meeting on May 11, 2026, to approve audited standalone and consolidated financial results for Q4 and FY26. The Board will also consider recommending a final dividend. The company's trading window remains closed until 48 hours after the results announcement.
Rajputana Investment and Finance Ltd (BSE: 539090) confirmed it does not meet the SEBI 'Large Corporate' criteria for FY 2025-26. The company reported zero outstanding long-term borrowings as of March 31, 2026. Consequently, the mandatory debt-raising requirements for large corporates are not applicable to the company.
B.R.Goyal Infrastructure Limited confirmed it does not meet the SEBI 'Large Corporate' criteria for the financial year ended March 31, 2026. The company reported outstanding borrowings of ₹30.32 Crore and carries a BBB+ credit rating from CARE Ratings Limited.
Oswal Overseas Limited disclosed its outstanding borrowing as ₹25.66 Crore for the year ended March 31, 2026. The company confirmed it does not meet the SEBI criteria to be classified as a 'Large Corporate' (LC) for the financial year. This regulatory filing clarifies the company's borrowing status and compliance with debt-raising norms.
Mr. Chaitra Arora has resigned as Company Secretary and Compliance Officer of Vivanza Biosciences Limited, effective April 30, 2026. He is departing to pursue career opportunities outside the company. The board has acknowledged the resignation, noting no material reasons for his departure other than personal professional growth.
Artefact Projects Ltd submitted its initial disclosure regarding the SEBI Large Corporate framework. The company confirmed it does not qualify as a Large Corporate as of March 31, 2026, reporting zero outstanding borrowings and no credit rating.
Dai-ichi Karkaria Limited has scheduled a Board Meeting for May 8, 2026. The board will consider audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with a potential dividend recommendation. The company's trading window remains closed until 48 hours after the results are public.
Orient Electric Ltd has scheduled a Board meeting on May 8, 2026. The Board will consider audited financial results for the year ended March 31, 2026, and a final dividend for FY 2025-26. The trading window remains closed until May 10, 2026.
International Combustion (India) Limited has re-appointed Mr. Rana Pratap Singh as Whole-Time Director for a three-year term, effective May 1, 2026, to April 30, 2029. The appointment, recommended by the Nomination and Remuneration Committee, is subject to shareholder approval. Mr. Singh brings over 38 years of industry experience in engineering and operations.
Le Merite Exports Limited confirmed it does not fall under the SEBI 'Large Corporate' category for F.Y. 2025-26. The company cited outstanding borrowings below the threshold and a CRISIL BB+/Stable credit rating. Consequently, specialized disclosure requirements for fund raising via debt securities are not applicable.
5paisa Capital Limited has appointed M/s. A N S A & Associates LLP, Chartered Accountants, as its Internal Auditors for the Financial Year 2026-27. The appointment was approved by the Board following a recommendation from the Audit Committee. M/s. A N S A & Associates LLP is an established firm specializing in governance, risk, and internal audits.
Paragon Finance Limited (BSE: 531255) disclosed that it does not fall under the 'Large Corporate' category for FY 2025-26 per SEBI criteria. The company reported outstanding borrowings of ₹1.39 Crore as of March 31, 2026. Consequently, mandatory debt market borrowing requirements are not applicable to the company.
Genesys International is seeking shareholder approval via postal ballot for ₹220 Crore in material related party transactions and raising the authorized share capital to ₹45 Crore. The company also proposes raising up to ₹30 Crore in promoter loans, with a ₹22 Crore conversion option into equity shares.